| Prognostic relevance of integrated genetic profiling in acute myeloid leukemia JP Patel, M Gönen, ME Figueroa, H Fernandez, Z Sun, J Racevskis, ... New England Journal of Medicine 366 (12), 1079-1089, 2012 | 2334 | 2012 |
| Anthracycline dose intensification in acute myeloid leukemia HF Fernandez, Z Sun, X Yao, MR Litzow, SM Luger, EM Paietta, ... New England Journal of Medicine 361 (13), 1249-1259, 2009 | 1120 | 2009 |
| The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells CT Jordan, D Upchurch, SJ Szilvassy, ML Guzman, DS Howard, ... Leukemia 14 (10), 1777-1784, 2000 | 1036 | 2000 |
| Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells ML Guzman, SJ Neering, D Upchurch, B Grimes, DS Howard, DA Rizzieri, ... Blood, The Journal of the American Society of Hematology 98 (8), 2301-2307, 2001 | 1000 | 2001 |
| Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study AK Fielding, SM Richards, R Chopra, HM Lazarus, MR Litzow, G Buck, ... Blood 109 (3), 944-950, 2007 | 920 | 2007 |
| In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and … AH Goldstone, SM Richards, HM Lazarus, MS Tallman, G Buck, ... Blood, The Journal of the American Society of Hematology 111 (4), 1827-1833, 2008 | 894 | 2008 |
| Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer EA Stadtmauer, A O'Neill, LJ Goldstein, PA Crilley, KF Mangan, JN Ingle, ... New England Journal of Medicine 342 (15), 1069-1076, 2000 | 543 | 2000 |
| PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia Z Gu, ML Churchman, KG Roberts, I Moore, X Zhou, J Nakitandwe, ... Nature genetics 51 (2), 296-307, 2019 | 481 | 2019 |
| T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993) DI Marks, EM Paietta, AV Moorman, SM Richards, G Buck, G DeWald, ... Blood, The Journal of the American Society of Hematology 114 (25), 5136-5145, 2009 | 442 | 2009 |
| High frequency and poor outcome of Philadelphia chromosome–like acute lymphoblastic leukemia in adults KG Roberts, Z Gu, D Payne-Turner, K McCastlain, RC Harvey, IM Chen, ... Journal of Clinical Oncology 35 (4), 394-401, 2017 | 429 | 2017 |
| UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia AK Fielding, JM Rowe, G Buck, L Foroni, G Gerrard, MR Litzow, ... Blood, The Journal of the American Society of Hematology 123 (6), 843-850, 2014 | 410 | 2014 |
| Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia S Li, FE Garrett-Bakelman, SS Chung, MA Sanders, T Hricik, F Rapaport, ... Nature medicine 22 (7), 792-799, 2016 | 385 | 2016 |
| A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403 W Stock, SM Luger, AS Advani, J Yin, RC Harvey, CG Mullighan, ... Blood, The Journal of the American Society of Hematology 133 (14), 1548-1559, 2019 | 380 | 2019 |
| Clonal selection with RAS pathway activation mediates secondary clinical resistance to selective FLT3 inhibition in acute myeloid leukemia CM McMahon, T Ferng, J Canaani, ES Wang, JJD Morrissette, ... Cancer discovery 9 (8), 1050-1063, 2019 | 364 | 2019 |
| Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation … AK Fielding, JM Rowe, SM Richards, G Buck, AV Moorman, IJ Durrant, ... Blood, The Journal of the American Society of Hematology 113 (19), 4489-4496, 2009 | 362 | 2009 |
| Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer AP Rapoport, EA Stadtmauer, N Aqui, A Badros, J Cotte, L Chrisley, ... Nature medicine 11 (11), 1230-1237, 2005 | 362 | 2005 |
| In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides. MZ Ratajczak, JA Kant, SM Luger, N Hijiya, J Zhang, G Zon, AM Gewirtz Proceedings of the National Academy of Sciences 89 (24), 11823-11827, 1992 | 307 | 1992 |
| Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS SM Luger, O Ringdén, MJ Zhang, WS Pérez, MR Bishop, M Bornhauser, ... Bone marrow transplantation 47 (2), 203-211, 2012 | 303 | 2012 |
| Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease R Reshef, SM Luger, EO Hexner, AW Loren, NV Frey, SD Nasta, ... New England Journal of Medicine 367 (2), 135-145, 2012 | 296 | 2012 |
| Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide P Westervelt, RA Brown, DR Adkins, H Khoury, P Curtin, D Hurd, ... Blood, The Journal of the American Society of Hematology 98 (2), 266-271, 2001 | 294 | 2001 |
Saar Gill在 pennmedicine.upenn.edu 的电子邮件经过验证
